Skip to main content

SeaStar Medical Holding Corp

For the period ended Mar 31, 2024. Filed May 14, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 14, 2024

ICU$1.90-3.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

Condensed Consolidated Statements of Changes in Stockholders' Deficit

Stockholders' Deficit (unaudited)
Common Shares
SharesAmountAdditional Paid-In CapitalAccumulated DeficitTotal Stockholders' Deficit
Balance, December 31, 202212,699,668$1$67,739$(88,502)$(20,762)
Issuance of shares - equity line of credit378,006—1,108—1,108
Issuance of shares - commitment fee for equity line of credit218,842—1,000—1,000
Issuance of shares - prepaid forward contracts——1,870—1,870
Stock-based compensation——505—505
Net loss———(7,096)(7,096)
Balance, March 31, 202313,296,516$1$72,222$(95,598)$(23,375)
Balance, December 31, 202347,615,285$5$100,859$(114,734)$(13,870)
Issuance of shares - conversion of convertible notes12,697,79219,389—9,390
Issuance of shares - exercise of warrants8,801,83613,959—3,960
Issuance of shares - equity offering, net of issue costs6,304,54518,309—8,310
Stock-based compensation——434—434
Net loss———(12,697)(12,697)
Balance, March 31, 202475,419,458$8$122,950$(127,431)$(4,473)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.